Atorvastatin (AT), a well-established anti-atherosclerotic drug, treats atherosclerosis by inhibiting HMG-CoA reductase in the liver, thereby reducing cholesterol synthesis and lowering LDL-C, TC, and TG levels. The gene discussed is HMGCR; the disease is atherosclerosis.